Abstract: The present invention relates to a human factor assessment method and system for autonomous driving. The human factor assessment method of autonomous driving includes generating an autonomous driving system twin based on autonomous driving system specifications and autonomous driving service logic, generating one or more human twins based on a human twin characteristic range, performing a simulation using the autonomous driving system twin and the human twin, and calculating a performance index of the autonomous driving service based on the simulation result.

Abstract: A cathode active material for a lithium secondary battery includes a lithium-nickel metal oxide particle having a form of a secondary particle in which a plurality of primary particles are aggregated therein. The lithium-nickel metal oxide particle includes a penetration region formed in an area extending from a surface to a point 70% or less of a radius of the particle in a direction to a center of the particle. The penetration region includes a tungsten compound at an interface between the primary particles. A relative standard deviation (RSD) value calculated from results of measuring a tungsten content from the surface of the secondary particle to a depth of 10 10 nm 10 times at different points using an X-ray Photoelectron Spectroscopy (XPS) is in a range from 10% to 40%.

Abstract: A cathode active material for a lithium secondary battery includes a lithium-nickel-based metal oxide particle, and a coating formed on a surface of the lithium-nickel-based metal oxide particle. The coating includes a water-soluble polymer and an oxygen scavenger compound. Oxygen generated from the cathode active material can be directly removed by the coating.

Abstract: A detection device includes a substrate, first electrodes formed on a first surface of the substrate, a responsive layer, and second electrodes formed on a first surface of the responsive layer, each of the second electrodes are capacitively coupled to one of the first electrodes and each second electrode is connected to a power supply to provide driving power.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: An electrically heated smoking article includes a filter layer, a hollow tube layer stacked at a lower end of the filter layer, an aerosol-forming substrate layer stacked below the hollow tube layer and including a mixture of a solid moisture absorbent and a liquid aerosol-forming substrate capsule, and a wrapping portion surrounding the filter layer, the hollow tube layer, and the aerosol-forming substrate layer to maintain a stack structure. The liquid aerosol-forming substrate capsule includes a liquid aerosol-forming substrate at a center, a first emulsifier layer completely surrounding the liquid aerosol-forming substrate, and a first coating material layer covering a surface of the first emulsifier layer.

Abstract: An electrically heated smoking article includes a filter rod, an aerosol medium rod stacked at a lower end of the filter rod and including an aerosol medium that generates an aerosol by heating and a moisture absorbent accommodating or absorbing the aerosol medium, and a wrapping portion surrounding and wrapping the filter rod and the aerosol medium rod to maintain a stack structure. The aerosol medium, including glycerin and a thickener, is maintained in a semi-solid or solid state in a first temperature range including room temperature and is in a liquefied state in a second temperature range higher than the first temperature range. The glycerin vaporizes in a third temperature range higher than the second temperature range to generate an aerosol. The thickener does not vaporize in the third temperature range but remains in the moisture absorbent.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: A detection device includes a substrate, first electrodes formed on a first surface of the substrate, a responsive layer, and second electrodes formed on a first surface of the responsive layer, each of the second electrodes are capacitively coupled to one of the first electrodes and each second electrode is connected to a power supply to provide driving power.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: The present invention provides novel compounds of chemical formula 1, optical isomers of the compounds, or a pharmaceutically acceptable salts of the compounds, or the optical isomers. The compounds, isomers, and salts exhibits excellent activity as GLP-1 receptor agonists. Particularly, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used therapeutic agents for metabolic diseases. In addition, they exhibits excellent pharmacological safety for cardiovascular systems.

Abstract: Disclosed is a method for providing information in a server. Said method for providing information in a server includes: a step for repeatedly receiving at preset intervals, data related to a plurality of sensors provided in an electronic device; a step for storing the data received at the preset intervals; a step for comparing data corresponding to a first period and data corresponding to a second period among the stored data, and thereby sensing a change in the performance of the electronic device; and a step for providing guidance information corresponding to the sensed change in performance to a user terminal device which corresponds to the electronic device.

Abstract: Disclosed is a method for providing information in a server. Said method for providing information in a server includes: a step for repeatedly receiving at preset intervals, data related to a plurality of sensors provided in an electronic device; a step for storing the data received at the preset intervals; a step for comparing data corresponding to a first period and data corresponding to a second period among the stored data, and thereby sensing a change in the performance of the electronic device; and a step for providing guidance information corresponding to the sensed change in performance to a user terminal device which corresponds to the electronic device.

Abstract: A polycarbonate resin composition of the present invention comprises: a polycarbonate resin; and a polycarbonate polyol comprising a terminal hydroxyl group and a repeat unit represented by Formula 1. The polycarbonate resin composition exhibits good properties in terms of color, impact resistance, stiffness and the like even after irradiation with ionizing radiation.

Abstract: A polycarbonate resin composition of the present invention comprises: a polycarbonate resin; a polyalkylene glycol; an epoxy ester compound containing an ester group and an epoxy group; and a halogenated polycarbonate oligomer. The polycarbonate resin composition has excellent discoloration resistance, color, hydrolysis resistance, flame retardancy and the like even after being irradiated with ionizing radiation.

Abstract: The present disclosure relates to a deglycosylated antibody binding specifically to C-type lectin domain family 14, member A (clec14a). More particularly, the present disclosure relates to a deglycosylated antibody that comprises a light chain variable region comprising CDR1 having a certain sequence and binds specifically to clec14, and use thereof, for example, a pharmaceutical composition containing the antibody for preventing or treating an angiogenesis-related disease.

Abstract: A polycarbonate resin composition of the present invention comprises: a polycarbonate resin; and a polycarbonate polyol comprising a terminal hydroxyl group and a repeat unit represented by Formula 1. The polycarbonate resin composition exhibits good properties in terms of color, impact resistance, stiffness and the like even after irradiation with ionizing radiation.

Abstract: Disclosed herein is a polycarbonate resin composition. The polycarbonate resin composition includes: a polycarbonate resin; a polyalkylene glycol compound; and an anthraquinone colorant, wherein the polycarbonate resin composition has a yellow index (YI) of about ?2 to about 2, as measured in accordance with ASTM D1925 after irradiating an about 3.2 mm thick specimen with ?-rays at about 25 kGy and leaving the specimen for 7 days and has an a* value of about ?2 to about 2 and a b* value of ?2 to about 2 as measured in accordance with ASTM D2244 after irradiating an about 3.2 mm thick specimen with ?-rays at about 25 kGy and leaving the specimen for 7 days. The polycarbonate resin composition can exhibit excellent properties in terms of color, transparency, and impact resistance after being irradiated with ionizing radiation.

Abstract: A polycarbonate resin composition includes: a polycarbonate resin; a polyalkylene glycol compound; and an organic-inorganic hybrid pigment, and has a yellow index (YI) of about ?2 to about 4 after irradiation with gamma rays, as measured in accordance with ASTM D1925 after irradiating an about 3 mm thick specimen with gamma rays at about 25 kGy and leaving the specimen for 7 days. The polycarbonate resin composition can exhibit excellent properties in terms of color and impact resistance after being irradiated with ionizing radiation.